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Health
Access
Network
MeHAF Addiction Care Program

Overview
• The Maine Health Access Foundation (MeHAF) contracted with the
Cutler Institute at the University of Southern Maine to provide
evaluation services for the Addiction Care Program for three years.
Evaluation data was collected from a variety of sources, including
surveys, continuous quality improvement (CQI) data, and focus
groups.
• Over the course of the MeHAF grant period, the Cutler Institute
worked with Health Access Network (HAN) to set up a system to
collect data via a data dashboard, deploy surveys, and conduct
focus groups.
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Background Information
• In 2017, HAN was awarded a three-year grant from MeHAF to
create a hub-and-spoke system for Integrated Medication-Assisted
Treatment (IMAT).
• HAN engaged a regional network of partner organizations to
implement treatment programs, building on the traditional hub-andspoke model to emphasize a “no wrong door approach” for
patients accessing treatment services.

Year 1

April 2017 – March 2018

Year 2

April 2018 – March 2019

Year 3

April 2019 – March 2020
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Overview of Program Objectives
Year 1

Year 2

Year 3

• Increase the number of HAN
providers trained and certified to
prescribe Suboxone

• Complete necessary training to
ready system for pilot
implementation and expansion of
integrated, patient-centered
addiction care and MAT

• Complete the development of a
standard of care based substance
use disorder treatment program to
expand patient-centered
addiction care and MAT in
conjunction with community
partners

• Recruit and hire RN Care Manager
to assume responsibility for MAT
patient population
• Continue to expand the number
of patients being treated with MAT
• Continue to maintain professional
development, training and
supervision for MAT clinical
providers
• Identify/Develop resources that
help MAT patients improve their
social determinants of health

• Provide ongoing training and
supervision to improve patient
care outcomes
• Identify/Develop resources that
help MAT patients improve their
social determinants of health
• Provide SBIRT and MAT (Suboxone)
visit trainings with all clinical staff

• Provide ongoing training and
supervision to improve patient
care outcomes
• Provide formal education to front
line staff (Reception/MA)
regarding proper and respectful
practices for scheduling, rooming,
managing, and following up with
MAT patients
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Data and Methodology
CQI
Data
CQI
Data
• Measures designed
to assess the
adoption,
implementation, and
maintenance of MAT across all
grantee organizations
• Continuous monthly collection
for years 1, 2, and 3

Focus Group
• Change Team
focus group
• Conducted in
year 3
• Questions focused on
partner collaboration,
challenges and successes
of MAT implementation,
and sustainability
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Summary of Data

Throughout the three-year grant period, Health Access Network was able to successfully make use
of MeHAF’s funding to support and improve Opioid Use Disorder (OUD) care. Qualitative and
quantitative analysis of data collected over the course of the grant reveals several components
that contributed to HAN’s program development and success.

• Meeting the Needs of the Community
• Treatment Capacity
• Stakeholder Engagement and Training
• Organizational Capacity to Identify OUD
• Treatment Access
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Meeting the Needs of the Community
Despite initial staff uncertainty and unfamiliarity with treating OUD patients, the HAN MAT
Addiction Care Program received an average of over 2 referrals a month.

“The effect really has been to start in changing the
culture here. There’s still a lot more work to do
but…two-and-a-half years ago, Suboxone was
something that oh, they did that in the Medway
office and that was it. It wasn’t really widespread in
the organization.
…[Staff] didn't know what was going to happen.
That’s really just blossomed and it’s really been a
beautiful transition. That’s what I'm most proud of.
We still have a lot more work to do but the progress
we've made in just that has been huge.”

# of Patients Referred for Induction
9
8
7
6
5
4
3
2
1
0

*all quotes are from the year 3 Change Team focus group
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Treatment Capacity
Challenges to Expansion
Engaging Providers to Prescribe
-

Expansion of treatment capacity relies on the
program’s ability to engage new providers to
match an increase of patient intake

Changing Workflows
-

The treatment process must be adaptable to the
increase in providers
Workflow inefficiencies associated with prescriber
expansion hinder treatment quality and timeliness

Stigma
-

Stigma influenced staff attitudes and caused
misunderstandings of basic workflows among MA’s
Providers had limited understanding of OUD
prevalence and willingness to treat patients with
OUD

“[This project] has given us the opportunity to
help and to see a lot of our gap in providers—to
have them join the program so that we’re able
to have better access.”
“For me one of the bigger challenges has been
the process and from start to finish how we get
patients in the door. We had this process that
worked when we only had two prescribers
providing. Now that it’s turned into five
prescribers prescribing across different sites and
locations, the process we’re using isn't working
anymore.”
“Our reception was concerned that these people
would be in the waiting room. …We’re really just
trying to normalize it, and even providers feeling
like ‘We don't do that here. We don't have those
patients here,’ not actually recognizing that they
are our patients.”
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Treatment Capacity
Provider Treatment Capacity

Despite the challenges, HAN increased the
number of providers prescribing MAT from
3 in the beginning of Year 1 to
10 at the end of Year 2.
# of Providers Currently Prescribing
12

Stigma reduction and provider-to-provider
education helped to increase the number
of providers willing to prescribe MAT to
patients.

10
8
6
4

“So seeing [providers] do [MAT],
more providers are like ‘I can
do that. It makes sense.’”

2
0
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Stakeholder Engagement and Training
The Change Team emphasized the success of the following training strategies to
combat organizational stigma and increase provider capacity:
1. Simultaneously training providers to prescribe and educating peripheral staff “A big win was you have increased capacity on the prescriber side and also in
that time educated staff and providers on what it is you're doing.”
2. Regular inclusion of OUD education in both informal and formal meetings “Most of the work or progress we had made has just been constant
conversations, education within monthly staff meetings, provider meetings, that
sort of thing. Just keeping it constantly talked about.”
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Stakeholder Engagement and Training, cont.
In years 1 and 2, HAN hosted 19 public meetings engaging community partners in discussions
on recovery supports and social determinants of health.
“we are engaged with Save A Life and they do a phenomenal job in terms of
pulling vested partners in the community together.”
In years 1 and 2, HAN participated in 34 trainings and educational events. This included 13
virtual ECHO sessions where providers shared their experiences treating patients with OUD.
These sessions fostered peer support and increased provider competence and confidence in
prescribing MAT and treating their patients’ co-occurring disorders.
“A lot of the education has been provider to provider, which makes a big
difference. Speaking to a colleague is very different than sitting in a meeting.”
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Organizational Capacity to Identify OUD
HAN’s increase in diagnoses indicates expanded provider awareness to screen for and assess
OUD among the HAN patient population.
# of Patients Diagnosed with OUD in
Practice (documented to meet DSM-5
criteria for OUD moderate or severe)
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An increase in diagnoses:
− Expedites the treatment process,
improving program efficacy
− Improves organizational planning by
creating more accurate estimates of OUD
in the community
− Contributes to a reduction in provider
stigma

0
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Treatment Access
HAN’s improvements in treatment access are evidenced by an increase in MAT program
enrollment and a decrease in wait time from referral to induction.
# of Patients Currently Enrolled in MAT
Program
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Induction (days)
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HAN reduced the average wait time from referral to induction for new patients from
114 days in April 2017 to 60 days in March 2020.
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Next Steps
Formalized Advisory Council

“We’re actually just now starting to
put a patient advisory council
together which will lead patients
who are in the program. We’re
hoping to start that and put in a
more formalized way to gather the
information. But until now it’s been
an informal process.”

Comprehensive Care

“In a perfect world people could
come into our walk-in care, get
that immediate access, stabilize
and then see a primary care
provider.”
“The goal is whether they come in
for an abscess or “I need help”
that we can get them same-day
evaluation, medication, into the
program. That would be the goal.
We are not there yet.”

Structuring Recovery Groups
“For a while we were getting
feedback that initially the groups
had been a real strength of ours
and then some of our groups had
changed, so we started to see our
group members drop. People
weren't attending. Then we started
getting feedback from patients
about the reasons why that was. It
was unstructured. Things they
thought weren't working as well
now as in the past. So we’re
addressing with the new
behavioral health providers so that
has started to improve and
hopefully will continue.“
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Questions?
The Cutler Institute Evaluation Team, University of Southern Maine
Lindsey Smith, PhD, MSW
m.lindsey.smith@maine.edu
Rachel Gallo, MPH
rachel.gallo@maine.edu
Tyler Egeland, BA
tyler.egeland@maine.edu
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